1. Home
  2. RSLS

as 12-20-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Medical/Dental Instruments

Nasdaq

Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.

Founded: 2002 Country:
United States
United States
Employees: N/A City: SAN CLEMENTE
Market Cap: 3.1M IPO Year: 2007
Target Price: N/A AVG Volume (30 days): 30.3K
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -17.51 EPS Growth: N/A
52 Week Low/High: $4.09 - $29.00 Next Earning Date: 11-14-2024
Revenue: $8,183,000 Revenue Growth: -16.55%
Revenue Growth (this year): 17.47% Revenue Growth (next year): 20.00%

RSLS Daily Stock ML Predictions

SELLHOLDBUYas of 2 days ago

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use